These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11752221)

  • 61. Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 up-regulation during hepatitis C virus gene expression.
    Qadri I; Iwahashi M; Kullak-Ublick GA; Simon FR
    Mol Pharmacol; 2006 Aug; 70(2):627-36. PubMed ID: 16670373
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibitory effect of nitric oxide on the induction of cytochrome P450 3A4 mRNA by 1,25-dihydroxyvitamin D3 in Caco-2 cells.
    Hara H; Mitani N; Adachi T
    Free Radic Res; 2000 Sep; 33(3):279-85. PubMed ID: 10993481
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nitric oxide donors inhibit luciferase expression in a promoter-independent fashion.
    Fan X; Roy E; Zhu L; Murphy TC; Kozlowski M; Nanes MS; Rubin J
    J Biol Chem; 2003 Mar; 278(12):10232-8. PubMed ID: 12525497
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nitric oxide inhibits surfactant protein B gene expression in lung epithelial cells.
    Salinas D; Sparkman L; Berhane K; Boggaram V
    Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1153-65. PubMed ID: 12896877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity.
    Lee SS; Cha EY; Jung HJ; Shon JH; Kim EY; Yeo CW; Shin JG
    Hepatology; 2008 Aug; 48(2):635-45. PubMed ID: 18666237
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nrf2 Regulates the Expression of
    Siswanto FM; Handayani MDN; Firmasyah RD; Oguro A; Imaoka S
    Curr Drug Metab; 2023; 24(9):667-681. PubMed ID: 37916628
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Kinetic characterization of the nitric oxide toxicity for PC12 cells: effect of half-life time of NO release.
    Yamamoto T; Yuyama K; Nakamura K; Kato T; Yamamoto H
    Eur J Pharmacol; 2000 May; 397(1):25-33. PubMed ID: 10844095
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Posttranslational regulation of CYP2J2 by nitric oxide.
    Park JW; Lee CM; Cheng JS; Morgan ET
    Free Radic Biol Med; 2018 Jun; 121():149-156. PubMed ID: 29715548
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids.
    Wisely GB; Miller AB; Davis RG; Thornquest AD; Johnson R; Spitzer T; Sefler A; Shearer B; Moore JT; Miller AB; Willson TM; Williams SP
    Structure; 2002 Sep; 10(9):1225-34. PubMed ID: 12220494
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nitric oxide inhibits glucocorticoid-induced apoptosis of thymocytes by repressing the SRG3 expression.
    Jeong SM; Lee KY; Shin D; Chung H; Jeon SH; Seong RH
    J Biol Chem; 2004 Aug; 279(33):34373-9. PubMed ID: 15187086
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology.
    Dubois V; Staels B; Lefebvre P; Verzi MP; Eeckhoute J
    Cells; 2020 Sep; 9(10):. PubMed ID: 32998360
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systematic functional study of cytochrome P450 2D6 promoter polymorphisms in the Chinese Han population.
    Gong X; Liu Y; Zhang X; Wei Z; Huo R; Shen L; He L; Qin S
    PLoS One; 2013; 8(2):e57764. PubMed ID: 23469064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The antiviral role of nitric oxide.
    Mannick JB
    Res Immunol; 1995; 146(9):693-7. PubMed ID: 8852613
    [No Abstract]   [Full Text] [Related]  

  • 74. Nitric oxide down-regulates caveolin-3 levels through the interaction with myogenin, its transcription factor.
    Martínez-Moreno M; Martínez-Ruiz A; Alvarez-Barrientos A; Gavilanes F; Lamas S; Rodríguez-Crespo I
    J Biol Chem; 2007 Aug; 282(32):23044-54. PubMed ID: 17519233
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heterogeneous nuclear ribonucleoprotein G, nitric oxide, and oral carcinogenesis.
    Shin KH; Kang MK; Park NH
    Nitric Oxide; 2008 Sep; 19(2):125-32. PubMed ID: 18474262
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oleuropein-Induced Acceleration of Cytochrome P450-Catalyzed Drug Metabolism: Central Role for Nuclear Receptor Peroxisome Proliferator-Activated Receptor α.
    Malliou F; Andriopoulou CE; Gonzalez FJ; Kofinas A; Skaltsounis AL; Konstandi M
    Drug Metab Dispos; 2021 Sep; 49(9):833-843. PubMed ID: 34162688
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease.
    Morgan ET; Skubic C; Lee CM; Cokan KB; Rozman D
    Drug Metab Rev; 2020 Nov; 52(4):455-471. PubMed ID: 32898444
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sex steroid hormones differentially regulate CYP2D in female wild-type and CYP2D6-humanized mice.
    Konstandi M; Andriopoulou CE; Cheng J; Gonzalez FJ
    J Endocrinol; 2020 May; 245(2):301-314. PubMed ID: 32171179
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nitric oxide stimulates cellular degradation of human CYP51A1, the highly conserved lanosterol 14α-demethylase.
    Park JW; Byrd A; Lee CM; Morgan ET
    Biochem J; 2017 Sep; 474(19):3241-3252. PubMed ID: 28830911
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.